Validation study of the antineutrophil cytoplasmic antibody (ANCA) kidney risk score in Japanese patients with ANCA-associated glomerulonephritis
In 2018, the Antineutrophil Cytoplasmic Antibody (ANCA) Renal Risk Score (ARRS) was proposed as a prognostic tool for renal outcomes in patients with ANCA-associated glomerulonephritis (AAGN). Subsequently, a revised version of the ANCA Kidney Risk Score (AKRiS) was reported in 2024. Nonetheless, it...
Sparad:
| Huvudupphov: | , , , , , , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Taylor & Francis Group
2026-12-01
|
| Serie: | Renal Failure |
| Ämnen: | |
| Länkar: | https://www.tandfonline.com/doi/10.1080/0886022X.2026.2678630 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|
